Table 1.

Demographic and clinical features of the examined cohort of patients.

	Patients Treated with ASMs	Untreated Patients
Female, n (% of group)	22 (51)	5 (71)
Male, n (% of group)	21 (49)	2 (29)
Age, y, median (IQR)	7.9 (3.8–10.5)	6.7 (4.0–8.5)
Epilepsy types, n (% of group)
Focal	19 (44)	7 (100)
Generalized and focal	8 (19)	0 (0)
Generalized	16 (37)	0 (0)
Unknown	0 (0)	0 (0)
Etiology classification, n (% of group)
Genetic	28 (65)	7 (100)
Structural	4 (9)	0 (0)
Metabolic	0 (0)	0 (0)
Immune	0 (0)	0 (0)
Infectious	0 (0)	0 (0)
Unknown	11 (26)	0 (0)

Abbreviations: ASM = antiseizure medication; IQR = interquartile range.